Financial Gravity Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $1.96M | Buy |
+26,635
| New | +$1.96M | 0.43% | 62 |
|
2024
Q2 | $2.05M | Sell |
26,357
-21,376
| -45% | -$1.67M | 0.51% | 50 |
|
2024
Q1 | $3.22M | Buy |
47,733
+24,997
| +110% | +$1.69M | 0.43% | 58 |
|
2023
Q4 | $1.53M | Buy |
22,736
+22,661
| +30,215% | +$1.53M | 0.02% | 275 |
|
2023
Q3 | $4.89K | Buy |
75
+3
| +4% | +$196 | ﹤0.01% | 633 |
|
2023
Q2 | $6.73K | Buy |
72
+3
| +4% | +$280 | 0.02% | 429 |
|
2023
Q1 | $1.61K | Buy |
69
+1
| +1% | +$23 | 0.05% | 321 |
|
2022
Q4 | $6.2K | Sell |
68
-592
| -90% | -$54K | 0.03% | 358 |
|
2022
Q3 | $1.27K | Sell |
660
-528
| -44% | -$1.02K | 0.04% | 332 |
|
2022
Q2 | $1.53K | Hold |
1,188
| – | – | 0.05% | 297 |
|
2022
Q1 | $1.54K | Buy |
1,188
+86
| +8% | +$112 | 0.04% | 309 |
|
2021
Q4 | $1.36K | Buy |
1,102
+1,079
| +4,691% | +$1.33K | 0.03% | 360 |
|
2021
Q3 | $60K | Buy |
23
+22
| +2,200% | +$57.4K | 0.03% | 491 |
|
2021
Q2 | $60K | Hold |
1
| – | – | 0.02% | 506 |
|
2021
Q1 | $30 | Sell |
1
-1
| -50% | -$30 | ﹤0.01% | 613 |
|
2020
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 502 |
|
2020
Q2 | – | Sell |
-8
| Closed | -$342 | – | 84 |
|
2020
Q1 | $342 | Sell |
8
-39
| -83% | -$1.67K | ﹤0.01% | 626 |
|
2019
Q4 | $50K | Buy |
47
+20
| +74% | +$21.3K | 0.03% | 646 |
|
2019
Q3 | $1K | Sell |
27
-30
| -53% | -$1.11K | ﹤0.01% | 971 |
|
2019
Q2 | $2K | Sell |
57
-37
| -39% | -$1.3K | ﹤0.01% | 866 |
|
2019
Q1 | $4K | Buy |
+94
| New | +$4K | ﹤0.01% | 727 |
|
2018
Q3 | $3K | Buy |
77
+10
| +15% | +$390 | ﹤0.01% | 831 |
|
2018
Q2 | $3K | Sell |
67
-7
| -9% | -$313 | ﹤0.01% | 869 |
|
2018
Q1 | $3K | Buy |
+74
| New | +$3K | ﹤0.01% | 828 |
|